Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2013 | 06-2012 | 06-2011 | 06-2010 | 06-2009 | |
| Sales | 189,176 | 426,041 | 389,237 | 369,369 | 349,964 |
| Cost of Goods | 88,470 | 326,782 | 300,876 | 288,744 | 276,292 |
| Gross Profit | 100,706 | 99,259 | 88,361 | 80,625 | 73,672 |
| Operating Expenses | 79,793 | 73,529 | 66,474 | 59,641 | 56,595 |
| Operating Income | 20,913 | 25,730 | 21,887 | 20,984 | 17,077 |
| Interest Expense | 5,571 | 2,946 | 3,898 | 3,365 | 4,776 |
| Other Income | -2,864 | -5,964 | 525 | 113 | 3,802 |
| Pre-tax Income | 12,478 | 16,820 | 18,514 | 17,732 | 16,103 |
| Income Tax | 1,628 | 5,071 | 4,380 | 4,575 | 4,800 |
| Net Income Continuous | 10,850 | 11,749 | 14,134 | 13,157 | 11,303 |
| Net Income Discontinuous | 7,063 | N/A | N/A | N/A | N/A |
| Net Income | $17,913 | $11,749 | $14,134 | $13,157 | $11,303 |
| EPS Basic Total Ops | 0.21 | 0.16 | 0.19 | 0.18 | 0.16 |
| EPS Basic Continuous Ops | 0.12 | 0.16 | 0.19 | 0.18 | 0.16 |
| EPS Basic Discontinuous Ops | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.20 | 0.16 | 0.19 | 0.18 | 0.16 |
| EPS Diluted Continuous Ops | 0.12 | 0.16 | 0.19 | 0.18 | 0.16 |
| EPS Diluted Discontinuous Ops | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $40,720 | $34,112 | $34,309 | $30,514 | $29,783 |